Corrigendum
Menis J, Twelves CEribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancerBreast Cancer (London). 2011;3:101–111.Professor Twelves has received honoraria from Eisai.Original article 
Guardado en:
Autores principales: | Menis J, Twelves C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e510c612b4c54587af07e3a197d4c46b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer
por: Twelves C, et al.
Publicado: (2011) -
Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
por: Yardley DA
Publicado: (2019) -
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
por: Criscitiello C, et al.
Publicado: (2018) -
Corrigendum to Role of Testosterone Levels on the Combinatorial Effect of Extract and Enzalutamide on Androgen Dependent LNCaP Cells and in Patient Derived Cells
Publicado: (2021) -
BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
por: Larsen S, et al.
Publicado: (2015)